🇺🇸 FDA
Pipeline program

EXPAREL

402-C-125

Approved small_molecule active

Quick answer

EXPAREL for Postoperative Pain is a Approved program (small_molecule) at Pacira BioSciences with 2 ClinicalTrials.gov record(s).

Program details

Company
Pacira BioSciences
Indication
Postoperative Pain
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials